{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T18:17:46Z","timestamp":1786558666922,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A cell-free approach using secretomes derived from stem cells or peripheral blood mononuclear cells is an active area of regenerative medicine that holds promise for therapies. Regulatory authorities classify these secretomes as biological medicinal products, and non- clinical safety assessment thus falls under the scope of ICH S6. A secretome of stressed peripheral blood mononuclear cells (APOSEC) was successfully tested in a toxicology program, supporting clinical use of the new drug candidate. Here, to allow for topical, dermal treatment of patients with diabetic foot ulcer, several non-clinical safety studies were performed. Acute toxicity (single dose) and neuropharmacological screening were tested intravenously in a rat model. Risk for skin sensitisation was tested in mice. A 4-week intravenous toxicity study in mice and a 4-week subcutaneous toxicity study in minipigs were conducted to cover the clinical setting and application in a rodent and a non-rodent model. Acute and repeated-dose toxicity studies show that APOSEC administered intravenously and subcutaneously does not involve major toxicities or signs of local intolerance at levels above the intended total human maximal dose of 3.3\u2009U\/kg\/treatment, 200\u2009U\/wound\/treatment, and 100\u2009U\/cm<jats:sup>2<\/jats:sup>\/treatment. The non-clinical data support the safe topical use of APOSEC in skin diseases related to deficient wound healing.<\/jats:p>","DOI":"10.1038\/s41598-019-42057-5","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T10:17:37Z","timestamp":1554286657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Toxicological testing of allogeneic secretome derived from peripheral mononuclear cells (APOSEC): a novel cell-free therapeutic agent in skin disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Silvio","family":"Wuschko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Gugerell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Chabicovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Hofbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Laggner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Erb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Ostler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Peterbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Suessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0601-0667","authenticated-orcid":false,"given":"Svitlana","family":"Demyanets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jost","family":"Leuschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6892-925X","authenticated-orcid":false,"given":"Michael","family":"Mildner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik J.","family":"Ankersmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"42057_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nm0405-367","volume":"11","author":"M Gnecchi","year":"2005","unstructured":"Gnecchi, M. et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nature medicine 11, 367\u2013368, https:\/\/doi.org\/10.1038\/nm0405-367 (2005).","journal-title":"Nature medicine"},{"key":"42057_CR2","doi-asserted-by":"publisher","first-page":"e107001","DOI":"10.1371\/journal.pone.0107001","volume":"9","author":"I Linero","year":"2014","unstructured":"Linero, I. & Chaparro, O. Paracrine effect of mesenchymal stem cells derived from human adipose tissue in bone regeneration. Plos one 9, e107001, https:\/\/doi.org\/10.1371\/journal.pone.0107001 (2014).","journal-title":"Plos one"},{"key":"42057_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2217\/rme.09.74","volume":"5","author":"PR Baraniak","year":"2010","unstructured":"Baraniak, P. R. & McDevitt, T. C. Stem cell paracrine actions and tissue regeneration. Regenerative medicine 5, 121\u2013143, https:\/\/doi.org\/10.2217\/rme.09.74 (2010).","journal-title":"Regenerative medicine"},{"key":"42057_CR4","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.yexcr.2010.02.026","volume":"316","author":"MN Walter","year":"2010","unstructured":"Walter, M. N., Wright, K. T., Fuller, H. R., MacNeil, S. & Johnson, W. E. Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays. Experimental cell research 316, 1271\u20131281, https:\/\/doi.org\/10.1016\/j.yexcr.2010.02.026 (2010).","journal-title":"Experimental cell research"},{"key":"42057_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3727\/096368910X550198","volume":"20","author":"TL Yew","year":"2011","unstructured":"Yew, T. L. et al. Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation. Cell transplantation 20, 693\u2013706, https:\/\/doi.org\/10.3727\/096368910X550198 (2011).","journal-title":"Cell transplantation"},{"key":"42057_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.healun.2010.08.023","volume":"30","author":"D Angoulvant","year":"2011","unstructured":"Angoulvant, D. et al. Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation 30, 95\u2013102, https:\/\/doi.org\/10.1016\/j.healun.2010.08.023 (2011).","journal-title":"The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation"},{"key":"42057_CR7","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1089\/scd.2011.0674","volume":"21","author":"ST Hsiao","year":"2012","unstructured":"Hsiao, S. T. et al. Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. Stem cells and development 21, 2189\u20132203, https:\/\/doi.org\/10.1089\/scd.2011.0674 (2012).","journal-title":"Stem cells and development"},{"key":"42057_CR8","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1093\/eurheartj\/ehn456","volume":"29","author":"M Korf-Klingebiel","year":"2008","unstructured":"Korf-Klingebiel, M. et al. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. European heart journal 29, 2851\u20132858, https:\/\/doi.org\/10.1093\/eurheartj\/ehn456 (2008).","journal-title":"European heart journal"},{"key":"42057_CR9","doi-asserted-by":"publisher","unstructured":"Wagner, T. et al. Different pro-angiogenic potential of gamma-irradiated PBMC-derived secretome and its subfractions. Scientific reports 8, 18016, https:\/\/doi.org\/10.1038\/s41598-018-36928-6 (2018).","DOI":"10.1038\/s41598-018-36928-6"},{"key":"42057_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/srep25168","volume":"6","author":"S Hacker","year":"2016","unstructured":"Hacker, S. et al. Paracrine Factors from Irradiated Peripheral Blood Mononuclear Cells Improve Skin Regeneration and Angiogenesis in a Porcine Burn Model. Scientific reports 6, 25168, https:\/\/doi.org\/10.1038\/srep25168 (2016).","journal-title":"Scientific reports"},{"key":"42057_CR11","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1007\/s10495-016-1292-8","volume":"21","author":"L Beer","year":"2016","unstructured":"Beer, L., Mildner, M., Gyongyosi, M. & Ankersmit, H. J. Peripheral blood mononuclear cell secretome for tissue repair. Apoptosis 21, 1336\u20131353, https:\/\/doi.org\/10.1007\/s10495-016-1292-8 (2016).","journal-title":"Apoptosis"},{"key":"42057_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.12688\/f1000research.4219.2","volume":"3","author":"P Altmann","year":"2014","unstructured":"Altmann, P. et al. Secretomes of apoptotic mononuclear cells ameliorate neurological damage in rats with focal ischemia. F1000 Research 3, 131, https:\/\/doi.org\/10.12688\/f1000research.4219.2 (2014).","journal-title":"F1000 Research"},{"key":"42057_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.expneurol.2015.03.013","volume":"267","author":"T Haider","year":"2015","unstructured":"Haider, T. et al. The secretome of apoptotic human peripheral blood mononuclear cells attenuates secondary damage following spinal cord injury in rats. Experimental neurology 267, 230\u2013242, https:\/\/doi.org\/10.1016\/j.expneurol.2015.03.013 (2015).","journal-title":"Experimental neurology"},{"key":"42057_CR14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/eurheartj\/ehs459","volume":"36","author":"K Hoetzenecker","year":"2013","unstructured":"Hoetzenecker, K. et al. Mononuclear cell secretome protects from experimental autoimmune myocarditis. European heart journal 36, 676\u2013685, https:\/\/doi.org\/10.1093\/eurheartj\/ehs459 (2013).","journal-title":"European heart journal"},{"key":"42057_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06223-x","volume":"7","author":"E Simader","year":"2017","unstructured":"Simader, E. et al. Safety and tolerability of topically administered autologous, apoptotic PBMC secretome (APOSEC) in dermal wounds: a randomized Phase 1 trial (MARSYAS I). Scientific reports 7, 6216, https:\/\/doi.org\/10.1038\/s41598-017-06223-x (2017).","journal-title":"Scientific reports"},{"key":"42057_CR16","doi-asserted-by":"publisher","unstructured":"Gugerell, A. et al. Viral safety of APOSECTM: a novel peripheral blood mononuclear cell derived-biological for regenerative medicine . Blood Transfusion, https:\/\/doi.org\/10.2450\/2019.0249-18 (2019 Feb 21).","DOI":"10.2450\/2019.0249-18"},{"key":"42057_CR17","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00395-011-0224-6","volume":"106","author":"M Lichtenauer","year":"2011","unstructured":"Lichtenauer, M. et al. Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study. Basic research in cardiology 106, 1283\u20131297, https:\/\/doi.org\/10.1007\/s00395-011-0224-6 (2011).","journal-title":"Basic research in cardiology"},{"key":"42057_CR18","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1016\/j.biomaterials.2013.12.071","volume":"35","author":"N Pavo","year":"2014","unstructured":"Pavo, N. et al. Long-acting beneficial effect of percutaneously intramyocardially delivered secretome of apoptotic peripheral blood cells on porcine chronic ischemic left ventricular dysfunction. Biomaterials 35, 3541\u20133550, https:\/\/doi.org\/10.1016\/j.biomaterials.2013.12.071 (2014).","journal-title":"Biomaterials"},{"key":"42057_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep16662","volume":"5","author":"L Beer","year":"2015","unstructured":"Beer, L. et al. Analysis of the Secretome of Apoptotic Peripheral Blood Mononuclear Cells: Impact of Released Proteins and Exosomes for Tissue Regeneration. Scientific reports 5, 16662, https:\/\/doi.org\/10.1038\/srep16662 (2015).","journal-title":"Scientific reports"},{"key":"42057_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1365-2362.2009.02111.x","volume":"39","author":"HJ Ankersmit","year":"2009","unstructured":"Ankersmit, H. J. et al. Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. European journal of clinical investigation 39, 445\u2013456, https:\/\/doi.org\/10.1111\/j.1365-2362.2009.02111.x (2009).","journal-title":"European journal of clinical investigation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42057-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42057-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42057-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:22:17Z","timestamp":1671265337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42057-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42057"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42057-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"20 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Medical University of Vienna has claimed financial interest. Aposcience AG holds patents related to this work (EP20080450198, EP20080450199, and EP17209165). H.J.A. is shareholder of APOSCIENCE AG. All other authors declare no potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5598"}}